Evidence map›Paper›PMID 36968958›Full record

ArticleOpen forum infectious diseases2023

Nolan R Holbrook, Erik H Klontz, Gordon C Adams, Samuel R Schnittman, Nicolas C Issa, Sheila A Bond, John A Branda, Jacob E Lemieux

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. DoTropical medicine and infectious disease · 2024
    Article
  7. Tafenoquine for Relapsing Babesiosis: A Case Series.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nolan R HolbrookDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-8764-0507
Erik H KlontzDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Gordon C AdamsInfectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Samuel R SchnittmanDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Nicolas C IssaDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Sheila A BondDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
John A BrandaDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jacob E LemieuxInfectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Massachusetts General Hospital · USBrigham and Women's Hospital · US

Funding

Microbial Determinants of Clinical Heterogeneity in Lyme DiseaseR00AI148604 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LEMIEUX, JACOB ERIC · 2022 to 2023
$500k
Microbial Determinants of Clinical Heterogeneity in Lyme DiseaseK99AI148604 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LEMIEUX, JACOB ERIC · 2020 to 2021
$273k
NIAID NIH HHS K99 AI148604NIAID NIH HHS R00 AI148604
6 · The paper itself

Abstract

We report

Indexed as

atovaquoneBabesia microtibabesiosisimmunocompromisedresistance

Identifiers

PMID36968958
PMCPMC10034591
OpenAlexW4321607013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.